Significance of anti-Mi2 antibodies in polymyositis (PM) and dermatomyositis (DM).

被引：0
|
作者：
Roux, S
Palazzo, E
Moosbrugger, I
Haim, T
Hayem, G
Renz, M
Hachulla, E
Kahn, MF
Seelig, HP
Meyer, O
机构：
[1] HOP BICHAT,F-75877 PARIS,FRANCE
[2] CLAUDE HURIEZ HOSP,LILLE,FRANCE
[3] INST IMMUNOL & MOL GENET,KARLSRUHE,GERMANY
来源：
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：702 / 702
页数：1
相关论文
共 50 条
  • [31] Incidence of specific cancer types in dermatomyositis (DM) and polymyositis (PM): Combined Scandinavian data.
    Hill, CI
    Zhang, YQ
    Sigurgeirsson, B
    Mellemkjaer, I
    Pukkala, E
    Airio, A
    Evans, SR
    Felson, DT
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S298 - S298
  • [32] Dramatic perturbations of T cell receptor (TCR) repertoire evidenced in polymyositis (PM) but not in dermatomyositis (DM).
    Benveniste, O
    Boyer, O
    Herson, S
    Klatzmann, D
    Cherin, P
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S195 - S195
  • [33] Prognostic Factors in Polymyositis/Dermatomyositis Patients with Anti-Synthetase Antibodies
    Taniguchi, Masashi
    Nakashima, Ran
    Kuramoto, Nobuo
    Murakami, Kosaku
    Hashimoto, Motomu
    Yoshifuji, Hajime
    Tanaka, Masao
    Ohmura, Koichiro
    Mimori, Tsuneyo
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [34] Transcriptional Derepression of CHD4/NuRD-regulated Genes in the Muscle of Patients with Dermatomyositis and anti-Mi2 Autoantibodies
    Pinal-Fernandez, Iago
    Cesar Milisenda, Jose
    Pak, Katherine
    Munoz-Braceras, Sandra
    Casal-Dominguez, Maria
    Torres-Ruiz, Jose Jiram
    Dell'Orso, Stefania
    Naz, Faiza
    Gutierrez-Cruz, Gustavo
    Duque-Jaimez, Yaiza
    Matas-Garcia, Ana
    Padrosa, Joan
    Garcia-Garcia, Francesc J.
    Guitart-Manpel, Mariona
    Garrabou, Gloria
    Trallero-Araguas, Ernesto
    Wallit, Brian
    Paik, Julie
    Albayda, Jemima
    Christopher-Stine, Lisa
    Lloyd, Tom
    Maria Grau, Josep
    Selva-O'Callaghan, Albert
    Mammen, Andrew
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4879 - 4882
  • [35] Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis
    Komura, K
    Fujimoto, M
    Matsushita, T
    Kaji, K
    Kondo, M
    Hirano, T
    Orito, H
    Horikawa, M
    Hamaguchi, Y
    Hasegawa, M
    Takehara, K
    Sato, S
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2005, 40 (03) : 215 - 217
  • [36] Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy
    Monseau, Gregoire
    Landon-Cardinal, Oceane
    Stenzel, Werner
    Schoindre, Yoland
    Mariampillai, Kuberaka
    Barete, Stephane
    Martel, Clothilde
    Masseau, Agathe
    Meyer, Alain
    Terrier, Benjamin
    Guegan, Sarah
    Verneuil, Laurence
    Audia, Sylvain
    Livideanu, Cristian Bulai
    Hachulla, Eric
    Kahn, Jean-Emmanuel
    Kahn, Jean-Emmanuel
    Lefevre, Guillaume
    Maurier, Francois
    Moulis, Guillaume
    Papo, Thomas
    Dossier, Antoine
    Descamps, Vincent
    Salort-Campana, Emmanuelle
    Richard, Marie-Aleth
    Bergot, Emmanuel
    Mortier, Laurent
    Costedoat-Chalumeau, Nathalie
    Genot, Severine
    Perez, Florian
    Piette, Anne-Marie
    Samson, Maxime
    Schleinitz, Nicolas
    Zenone, Thierry
    Lacoste, Marie
    de Boysson, Hubert
    Madaule, Serge
    Rigolet, Aude
    Champtiaux, Nicolas
    Hervier, Baptiste
    Bouvier, Anne-Marie
    Jooste, Valerie
    Leonard-Louis, Sarah
    Maisonobe, Thierry
    Aouba, Achille
    Benveniste, Olivier
    Bienvenu, Boris
    Allenbach, Yves
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : 1759 - 1763
  • [37] CLINICAL COURSES AND PREGNANCY OUTCOMES OF EIGHT CASES COMPLICATED WITH POLYMYOSITIS/DERMATOMYOSITIS (PM/DM) IN SINGLE CENTER
    Mino, R.
    Shimada, H.
    Wakiya, R.
    Nakashima, S.
    Kato, M.
    Miyagi, T.
    Sugihara, K.
    Ushio, Y.
    Mizusaki, M.
    Kameda, T.
    Dobashi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1472 - 1472
  • [38] Lung histopathological analysis is useful to predict the outcome of interstitial pneumonia in patients with polymyositis (PM)/dermatomyositis (DM).
    Yamasaki, M
    Yamada, H
    Yamasaki, Y
    Ohkubo, M
    Yoshida, T
    Hama, N
    Ozaki, S
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S488 - S488
  • [39] ANTIBODY TO JO-1 IN POLYMYOSITIS DERMATOMYOSITIS (PM/DM) - ASSOCIATION WITH INTERSTITIAL PULMONARY-DISEASE
    HOCHBERG, MC
    FELDMAN, D
    ARNETT, FC
    STEVENS, MB
    REICHLIN, M
    CLINICAL RESEARCH, 1984, 32 (03): : A719 - A719
  • [40] THE ASSOCIATION BETWEEN MI-2 ANTIBODIES AND DERMATOMYOSITIS
    TARGOFF, IN
    REICHLIN, M
    ARTHRITIS AND RHEUMATISM, 1985, 28 (07): : 796 - 803
12345